Systematic evaluation of salivary gland damage following high dosage I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up

被引：0
|
作者：
Wu, Juqing
Ouyang, Wei
Feng, Huijuan
Sun, Yungang
Chen, Pan
Wang, Jing
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
535
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic implications of diffuse hepatic uptake following I-131 therapy for differentiated thyroid cancer.
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Sakaguchi, Miki
    Uno, Takahiro
    Ishitoya, Shunta
    Sato, Junichi
    Takahashi, Koji
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [42] Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients
    Hollingsworth, Brynn
    Senter, Leigha
    Zhang, Xiaoli
    Brock, Guy N.
    Jarjour, Wael
    Nagy, Rebecca
    Brock, Pamela
    Coombes, Kevin R.
    Kloos, Richard T.
    Ringel, Matthew D.
    Sipos, Jennifer
    Lattimer, Ilene
    Carrau, Ricardo
    Jhiang, Sissy M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (11): : 4085 - 4093
  • [43] CLINICAL UTILITY OF THALLIUM -201(TL) SCINTIGRAPHY IN THE FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER
    MURTHY, S
    WEBNER, P
    MECHANICK, JI
    MORRIS, JC
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P167 - P167
  • [44] Significance of Salivary Gland Radioiodine Retention on Post-ablation 131I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma
    Jo K.S.
    An Y.-S.
    Lee S.J.
    Soh E.-Y.
    Lee J.
    Chung Y.-S.
    Kim D.J.
    Yoon S.-H.
    Lee D.H.
    Yoon J.-K.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (3) : 203 - 211
  • [45] Effects of I-131 ablation/metastasis treatment on DNA damage parameters in patients with differentiated thyroid cancer
    Toprak, E. K.
    Sengoz, T.
    Yaylali, O.
    Erkek, O. K.
    Ozdemir, Y.
    Oymak, B.
    Senol, H.
    Kucukatay, M. B.
    Kucukatay, V.
    Yuksel, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S599 - S599
  • [46] THYROGLOBULIN MEASUREMENT VS I-131 TOTAL-BODY SCAN FOR FOLLOW-UP OF WELL-DIFFERENTIATED THYROID-CANCER
    AIELLO, DP
    MANNI, A
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (02) : 437 - 439
  • [47] A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Sakaguchi, Miki
    Ishitoya, Shunta
    Uno, Takahiro
    Sato, Junichi
    Takahashi, Koji
    MEDICINE, 2015, 94 (28)
  • [48] CAN SERUM THYROGLOBULIN MEASUREMENT REPLACE WHOLE-BODY I-131 SCAN IN THE FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER
    FUI, ST
    HOFFENBERG, R
    BLACK, E
    MAISEY, MN
    ANNALES D ENDOCRINOLOGIE, 1979, 40 (05) : A3 - A3
  • [49] A CYTOGENETIC FOLLOW-UP-STUDY OF THYROID-CANCER PATIENTS TREATED WITH I-131
    GUTIERREZ, S
    CARBONELL, E
    GALOFREA, P
    XAMENA, N
    CREUS, A
    MARCOS, R
    CANCER LETTERS, 1995, 91 (02) : 199 - 204
  • [50] Incremental diagnostic value of SPECT/CT on I-131 scintigraphy in radioiodine therapy for patients with well differentiated thyroid carcinoma
    Maruoka, Yasuhiro
    Abe, Koichiro
    Baba, Shingo
    Sawamoto, Hirofumi
    Tanabe, Yoshitaka
    Sasaki, Masayuki
    Honda, Hiroshi
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
12345